NCT05434390

Brief Summary

The clinical study will evaluate the feasibility and acceptability of a culturally tailored behavioral intervention to improve uptake of pre-exposure prophylaxis for HIV prevention among at-risk Latino men who have sex with men.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 9, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 28, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

October 3, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

1.9 years

First QC Date

June 9, 2022

Last Update Submit

April 16, 2026

Conditions

Keywords

HIV preventionPre-exposure prophylaxisLatino men who have sex with men

Outcome Measures

Primary Outcomes (6)

  • PrEP initiation

    We will assess PrEP uptake using evidence of a prescription for Truvada® or Descovy® (participant shows us their prescription bottle in person or via a text photo).

    assessed at 1-month follow-up

  • PrEP initiation

    We will assess PrEP uptake using evidence of a prescription for Truvada® or Descovy® (participant shows us their prescription bottle in person or via a text photo).

    assessed at 3-month follow-up

  • PrEP adherence single measure

    We will assess adherence to the PrEP medication using a single-item self-rating adherence measure.

    assessed at 1-month follow-up

  • PrEP adherence single measure

    We will assess adherence to the PrEP medication using a single-item self-rating adherence measure.

    assessed at 3-month follow-up

  • PrEP adherence urine sample

    We will assess adherence to the PrEP medication by analyzing participants' urine sample to determine the presence of the medication tenofovir, a key medication in the PrEP medication.

    assessed at 1-month follow-up

  • PrEP adherence urine sample

    We will assess adherence to the PrEP medication by analyzing participants' urine sample to determine the presence of the medication tenofovir, a key medication in the PrEP medication.

    assessed at 3-month follow-up

Secondary Outcomes (2)

  • Changes in Readiness to Adopt PrEP

    assessed at 1-month follow-up

  • Changes in Readiness to Adopt PrEP

    assessed at 3-month follow-up

Study Arms (2)

Latino MSM PrEP intervention

EXPERIMENTAL

The Latino MSM PrEP intervention consists of 4 small group sessions with concurrent peer navigation and counseling.

Behavioral: Estoy PrEParado/ I am PrEPared intervention

Control condition

ACTIVE COMPARATOR

The control condition consists of usual care at the study site (i.e., referrals to PrEP services).

Behavioral: Usual Care

Interventions

Participants will receive an Information, Motivation, and Behavioral skills model PrEP intervention tailored for mixed immigrant status Latino men who have sex with men

Latino MSM PrEP intervention
Usual CareBEHAVIORAL

Participants will be offered PrEP navigation services as part of usual care at the study site.

Control condition

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility Detailscisgender male
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • assigned male at birth
  • Identifies as Latino/Hispanic origin
  • HIV-negative or HIV status unknown
  • Man who has had sex with other men in the past 24 months
  • Not currently using PrEP for HIV prevention

You may not qualify if:

  • Male under 18 years of age
  • Not identifying as being of Latino/Hispanic origin
  • Man who has not had sex with other men in the past 24 months
  • Identifies as cisgender or transgender Female/woman
  • Assigned female at birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bienestar Human Services

Los Angeles, California, 90022, United States

Location

Study Officials

  • Ronald A Brooks, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Parallel model. Participants will be randomly assigned to either an intervention or control arm of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 9, 2022

First Posted

June 28, 2022

Study Start

October 3, 2022

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

April 20, 2026

Record last verified: 2026-04

Locations